July 23, 2014 — Accuray Inc.’s CyberKnife and TomoTherapy systems have received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the U.S., according to the Q2 2014 MD Buyline Market Intelligence Briefing. The latest ratings show continuously improving customer satisfaction during the past one-and-a-half years as Accuray demonstrated significant and sustained improvements.
In rating Accuray, MD Buyline reports higher scores for system performance, system reliability, service response time and applications training for both the CyberKnife and TomoTherapy Systems. TomoTherapy System users believe the system is a workhorse, with the report indicating that they "love this system and believe that it is one of the best systems on the market for radiation oncology treatments." CyberKnife System users also conveyed positive experiences, stating they are "pleased with the level of flexibility the system allows" and that it is a "solid and durable system."
MD Buyline, an independent market intelligence organization for the healthcare industry, measures linear accelerator user satisfaction based on evaluations by more than 3,300 hospitals in its member network that use the product every day. Respondents rate how satisfied they are with products from Accuray, Elekta and Varian, using key metrics along with installation and implementation, applications training and service repair quality.
For more information: www.accuray.com
April 10, 2026 
